首页> 外文OA文献 >The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial : a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis

【2h】

The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial : a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis

机译：进行性炎症性脑病（CUPID）试验中的大麻素使用：一项随机双盲安慰剂对照平行组多中心试验和对大麻素在多发性硬化中延缓进展的经济评估

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

The National Institute for Health Research Health Technology Assessment programme, the Medical Research Council Efficacy and Mechanism Evaluation programme, Multiple Sclerosis Society and Multiple Sclerosis Trust.

机译：美国国立卫生研究院健康技术评估计划，医学研究理事会功效和机制评估计划，多发性硬化症学会和多发性硬化症基金会。

著录项

作者
Ball, Susan; Vickery, Jane; Hobart, Jeremy; Wright, Dave; Green, Colin; Shearer, James; Nunn, Andrew; Cano, Mayam Gomez; MacManus, David; Miller, David; Mallik, Shahrukh; Zajicek, John;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. The CUPID trial: a randomised double blind placebo-controlled parallel group multi-centre trial of cannabinoids to slow progression in multiple sclerosis [J] . Ball?S, Vickery?J, Hobart?J, Health technology assessment: HTA . 2015,第12期

机译：CUPID试验：大麻素减慢多发性硬化进程的随机双盲安慰剂对照平行组多中心试验
2. Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial. [J] . John Zajicek, Susan Ball, David Wright, Lancet Neurology . 2013,第9期

机译：屈大麻酚对进行性多发性硬化症（CUPID）进展的影响：一项随机，安慰剂对照的试验。
3. Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial [J] . Ravnborg Mads, Sorensen Per Soelberg, Andersson Magnus, Lancet Neurology . 2010,第7期

机译：甲基泼尼松龙与干扰素β-1a联合用于复发缓解型多发性硬化症（MECOMBIN研究）：一项多中心，双盲，随机，安慰剂对照，平行组试验
4. Magnetic resonance imaging evaluation and therapeutic trials in primary progressive multiple sclerosis. [D] . Leary, Siobhan Marie. 2002

机译：原发性进行性多发性硬化症的磁共振成像评估和治疗试验。
5. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis. [O] . Susan Ball, Jane Vickery, Jeremy Hobart, -1

机译：进行性炎性脑病（CUPID）试验中的大麻素使用：一项随机的双盲安慰剂对照平行组多中心试验并对大麻素减慢多发性硬化症的进展进行经济评估。
6. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis [O] . Shearer, James, Ball S, Vickery J, Hobart J, Wright D, Green C, Shearer J, Nunn A, Cano MG, MacManus D, Miller D, Mallik S, Zajicek J 2015

机译：在进行性炎症性脑病（CUPID）试验中使用大麻素：一项随机的双盲安慰剂对照平行组多中心试验和对大麻素减慢多发性硬化病进展的经济评价

The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial : a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅